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Transcription of thyroglobulin (Tg) gene is under the positive control of thyrotropin (TSH). The mechanism 
of this control has been further investigated. Rats were treated with triiodothyronine (T,) to decrease their 
endogenous TSH production. Following the intravenous injection of bovine TSH, a 3-fold stimulation of 
Tg gene transcription could be detected in isolated nuclei as early as 1 h after treatment. The TSH effect 
was also observed in tissue fragments incubated in vitro under conditions where a concomitant stimulation 
of CAMP accumulation was detected. Forskolin, a universal activator of adenylate cyclase, was able to 
mimic TSH action on Tg gene transcription. We conclude that TSH controls transcription of Tg gene direct- 
ly via its known “interaction with receptors on thyrocytes and that CAMP is a physiological mediator of 
this effect. 
Cyclic nucleotide Forskolin Thyrotropin Run-off assay 
1. INTRODUCTION 
Adenosine 3 ’ ,5 ’ -monophosphate (cyclic AMP) 
is a ubiquitous regulatory molecule active in both 
prokaryotes and eukaryotes. Transcriptional con- 
trol of gene expression by CAMP was first 
demonstrated in E. coli (review [ 11). Interaction of 
the lac promoter with CAMP-binding protein is 
studied as a general model for the binding of 
regulatory protein to DNA [2]. In eukaryotes, 
although CAMP is one of the 3 major signal 
molecules involved in intracellular regulation, 
evidence of transcription control by CAMP has 
been provided so far for a few genes only: 
discoidin I [3], lactate dehydrogenase [4], prolactin 
[5], phosphoenolpyruvate carboxykinase [6,7] and 
tyrosine aminotransferase [8]. 
Abbreviations: cDNA, complementary DNA; prTg, 
plasmids containing rat thyroglobulin cDNA fragment 
The pituitary hormone thyrotropin (thyroid- 
stimulating hormone, TSH) is the main agent 
regulating the activity of the thyroid gland. It may 
be considered as one of the prototype hormones 
acting via adenylate cyclase activation [9]. Stimula- 
tion of thyroid follicular cells by TSH results in 
their rapid functional activation leading to the syn- 
thesis and secretion of thyroid hormones. The lat- 
ter results from the hydrolysis of a precursor 
iodoprotein, thyroglobulin (Tg), synthesized in 
large amounts by the gland [lo, 111. The synthesis 
of Tg is under TSH control [12,13]. 
We have demonstrated that TSH controls 
transcription of the Tg gene in a tonic fashion 
when administered in vivo [14]. In the rat thyroid, 
the Tg gene was already maximally expressed 
under physiological conditions. However, the con- 
tinuous presence of TSH was required to maintain 
the gene in an activated state as hypophysectomy 
or triiodothyronine (Ts) administration profound- 
ly depressed its transcription [14]. Here, ex- 
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periments were performed to investigate the 
kinetics of restimulation of Tg gene transcription 
by TSH in Tj-treated rats and to determine 
whether CAMP played a role in this regulation. 
Our results indicate that the effect of TSH is 
rapid, is exerted directly on the thyroid cell and can 
be mimicked by forskolin, an agent known to in- 
crease the cytoplasmic level of CAMP. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Bovine TSH (bTSH; Thytropar) was obtained 
from Armour (Kankakee, 11); [32P]UTP, 400 
Ci/mmol (1 Ci = 37 GBq) from Amersham; T3 
(triiodo-L-thyronine, sodium salt) from Sigma, 
forskolin from Hoechst Pharmaceutical (Bombay) 
and Ro 20-1724 from Hoffman La Roche (Nutley, 
NJ). 
2.2. Handling of animals 
Albino male rats of the IUPA-OFA strain, 
weighing 180-240 g, were purchased from Iffa- 
Credo (St Germain sur YArbresle, France). 
T3-treated rats received the hormone is a single dai- 
ly dose intraperitoneally (5 rg/lOO g body wt). 
Alternatively, an equivalent amount was given in 
the drinking water. Bovine TSH was administered 
intravenously as a single dose of 0.2 unit/100 g 
body wt. 
Blood was obtained by cardiac puncture under 
ether anesthesia between 09.00 a.m. and 15.00 
p.m.. The animals were subsequently killed by 
decapitation, and the thyroid glands were removed 
and dissected free of connective tissue. 
2.3. Measurement of thyroxine in serum 
Thyroxine (Td) was measured using commercial 
reagents (Gammacoat-Clinical Assay). 
2.4. In vitro restimulation of the thyroid glands 
The thyroid lobes were cut in 4 pieces at room 
temperature. Randomly assorted pools of tissue 
from 5 animals were preincubated for 30 min at 
37°C under an atmosphere of 02:COz (95:5, v/v) 
in 2 ml Krebs Ringer bicarbonate buffer enriched 
with 8 mM glucose and 0.5 g/l bovine serum 
albumin. TSH or forskolin was added and the in- 
cubation continued for 150 min. At the end of the 
incubation, thyroid nuclei were isolated as de- 
scribed [14]. 
2.5. Measurement of thyroglobulin gene trans- 
cription in isolated nuclei 
The procedures have been detailed [14]. 
Thyroglobulin gene transcription was measured by 
hybridization of labeled nuclear RNA to im- 
mobilized plasmids containing fragments of rat Tg 
cDNA (prTg) [ 141. The total length of the cDNA 
inserts used in this study (prTg 32 and prTg 39) 
amounts to 70% of the Tg mRNA. 
2.6. Measurement of CAMP in the thyroid tissue 
Thyroid lobes were cut into 2 pieces at room 
temperature. Four pieces were incubated in 1 ml at 
37°C as described above. After 30 min preincuba- 
tion, TSH, forskolin or Ro 20-1724 was added to 
the medium and the tissue incubated for another 
30 min. The incubation was ended by boiling the 
tissue in water for 5 min and the CAMP concentra- 
tion determined by the method of Gilman, as 
described [IS]. 
3. RESULTS AND DISCUSSION 
3.1. Kinetics of TSH effects on Tg gene trans- 
cription 
In previous experiments the regulation of 
thyroglobulin gene transcription was studied in 
rats subjected to various manipulations leading to 
suppression or stimulation of their endogenous 
TSH production. Following the killing of the 
animals Tg gene transcription was measured in 
isolated thyroid nuclei using the ‘run-off assay’ 
[16]. Lowering the level of circulating TSH by 
hypophysectomy or T3 administration led to a 
dramatic decrease of Tg gene transcription which 
could be restored by administration of the hor- 
mone [14]. However, early times of the kinetics of 
restimulation by TSH could not be studied proper- 
ly because the level of Tg gene transcription in T3 
suppressed animals frequently dropped below the 
detection limit of our assay (around 100 ppm). 
This was mainly due to the fact that the cDNA 
probes used here represented only 20% of the 
thyroglobulin mRNA length [ 171. 
To provide larger probes, a rat thyroid cDNA 
library (Leriche, A., submitted) was screened with 
bovine Tg cDNA and 2 clones, prTg 32 and prTg 
39, were selected. Together, their insertions repre- 
sent 70% of the rat Tg m RNA. Using these new 
clones, the limit of detection of the transcription 
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Effect of the intravenous administration of TSH on transcription of thyroglobulin (Tg) gene in rats chronically treated 
with TX 
Rat treatmenta 
T3 (7 days) 
T3 (7 days) 
+ TSH (1 h) 
T3 (7 days) 
+ TSH (3 h) 
[32P]RNA input (32P]RNA to Hybridized 
hybridization filters cpm 
(cpm x 10m6) (pBR322) (prTg) 
2.40 12 166 
2.69 7 1.57 
1.81 8 389 
2.19 7 475 
2.99 18 830 
0.88 6 227 
Tg gene tran- 
scription 
(ppmb) 
Serum TdC 
(/lg/d1) 
208 
0.7 * 0.1 
147 
546 
1.3 f 0.3 
565 
718 
2.6 k 0.6 
662 
a Rats received a daily dose of 5 pg Ts/lOO g body wt for 7 days given in their drinking water. Thyroid tissue was ob- 
tained on the last day of T3 treatment, 1 or 3 h after a single injection (i.v.) of bTSH (0.2 III/100 g body wt). Control 
animals were killed 1 h after administration of a saline solution (0,9% NaCl) 
b The rate of Tg gene transcription in ppm was calculated as the difference between the cpm hybridized to prTg and 
pBR322 filters. The difference was divided by the total input radioactivity, corrected for the efficiency of hybridization 
between 25 and 5070, see [14]) and multiplied by 1.4 to account for the size ratio between the mRNA to the cDNA 
inserts 
’ T4 in serum was determined on blood samples obtained from individual rats and expressed as the mean + 1 SD 
Nuclei were prepared from 2 pools of 10 thyroid glands for each group of animals and transcription of the Tg gene 
was measured as described [141. The 32P-labeled transcripts were hybridized to filters containing immobilized DNA from 
pBR322 plasmid or from recombinant prTg plasmids. Results from individual transcription reactions are presented 
assay was reduced to 18 ppm. This allowed ac- 
curate measurement of Tg gene transcription in T3 
suppressed animals (178 + 43 ppm) and the detec- 
tion of an effect of TSH as early as 1 h after the 
intravenous administration of the hormone (table 
1). If one takes into account the exceptional size of 
the Tg gene (- 200 kb [18,19] and its expected 
transcription time (around 60 min [20]), this may 
be considered as a very rapid effect of TSH. At 
earlier times our measure of Tg transcription 
would be biased by the delay involved in the pro- 
gression along the gene of the stimulation wave. 
3.2. Stimulation by TSH of Tg gene transcription 
in incubated tissue 
To determine whether the observed effect 
resulted from a direct action of TSH on thyroid 
tissue, thyroid fragments from rats pretreated with 
T3 were incubated in vitro and challenged with 
TSH. As a preliminary to the measurement of Tg 
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gene transcription we checked that under the in- 
cubation conditions used, intracellular cyclic AMP 
accumulation could be stimulated by TSH and by 
the universal adenylate cyclase activator, forskolin 
as in thyroids of other species [21]. Although 
modest when compared to the effect observed in 
dog thyroid [21], both agents exerted a clear 
stimulatory effect which could be amplified by the 
addition of a phosphodiesterase inhibitor (Ro 
20-1724) to the incubation medium (fig.1). 
When Tg gene transcription was measured in 
tissue incubated for 150 min in the presence of 
TSH, a 2-fold stimulation was detected over the 
levels observed in control conditions (control, 101 
+ 36 ppm; stimulated, 195 + 83 ppm). Results 
from individual hybridization reactions are 
reported in table 2. In spite of some dispersion and 
of the expected lower magnitude of TSH effect 
when measured under in vitro conditions, they 
demonstrate that stimulation of Tg gene transcrip- 
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Fig. 1. Effect of bTSH and forskolin on CAMP ac- 
cumulation in rat thyroid cells in vitro. CAMP accumula- 
tion in thyroid cells was measured after incubation of the 
tissue in presence of the agents for 30 min, as described 
in section 2. The thyroid glands from rats treated for 3 
days with T3 were incubated under control conditions 
(C) or in the presence of 50 mu/ml bTSH (T) or lOaM 
forskolin (F). The effect of Ro 20-1724 (8 x 10m5 M), 
a phosphodiesterase inhibitor, was also investigated. 
Results are expressed as means f 1 SD in 1 typical ex- 
periment out of 3. 
tion is a direct effect of thyrotropin on the thyroid 
gland. 
3.3. Forskolin mimics TSH effect on Tg gene 
transcription 
While most TSH effects are mediated by CAMP 
in the dog thyroid [22], no such demonstration is 
available in the rat species. Also, there are clear ex- 
amples of TSH actions which are independent of 
CAMP [23]. Therefore, it was of interest to in- 
vestigate whether elevation of the intracellular con- 
centration of CAMP would alter Tg gene transcrip- 
tion. Thyroid fragments from Ts treated rats were 
incubated for 150 min in the presence or absence of 
forskolin (10pM). This agent clearly mimicked the 
TSH effect by producing 2-3-fold stimulation of 
gene transcription (control 77 + 17 ppm; 
stimulated, 218 + 46 ppm) (table 3). Interestingly, 
the fact that forskolin stimulated CAMP accumula- 
tion to a larger extent than TSH under our ex- 
Table 2 
Effect of TSH on transcription of the Tg gene in rat 
thyroid fragments incubated in vitro 
Incubation [32P]RNA [32P]RNA hybrid- TG gene 
conditions input/ to filters ized tran- 
hybrid- cmp scription 
ization (PBRW (pfk) (ppm”) 
@pm x 
10-6) 
Control 
2.49 17 69 65 
3.52 12 153 138 
3.43 15 131 100 
2.41 11 92 100 
TSH 3.71 16 304 240 
(50 
mu/ml) 4.52 10 365 246 
a Results are expressed as in table 1 
Rats received a daily dose of 5 pg T3/100 g body wt for 
5 days given in their drinking water. Thyroid tissue was 
obtained the last day of T3 treatment and was incubated 
for 150 min in control medium or in the presence of 
bTSH (50 mu/ml) as described in section 2. Nuclei were 
isolated from the incubated tissue and used in in vitro 
transcription experiments as described in table 1 
Table 3 
Effect of forskolin on transcription of Tg gene in rat 
thyroid fragments incubated in vitro 
Incubation [32P]RNA [32P]RNA hybrid- TG gene 
conditions input/ to filters ized tran- 
hybrid- cmp scription 
ization (pRR322) (prTg) (ppm”) 
(cpm x 
10-6) 
Control 
3,76 11 117 84 
4.17 11 60 58 
3.52 11 116 90 
Forskolin 
(IO PM) 
4.28 34 280 171 
4.22 27 332 222 
2.38 25 228 262 
a Results are expressed as in table 1 
Rats were treated as described in table 2. Tissue was in- 
cubated for 150 min in control medium or in the 
presence of forskolin (10 PM) as described in section 2. 
Nuclei were isolated from the incubated tissue and used 
in in vitro transcription experiments as described in 
table 1 
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perimental conditions (see fig.1) was not accom- 
panied by a stronger effect on Tg gene transcrip- 
tion. Similar observations have been made for 
other CAMP mediated effects of TSH [21,24]. 
4. CONCLUSIONS 
Our results confirm and extend previous data 
demonstrating a transcriptional control of Tg gene 
expression by TSH. Thyrotropin effect is rapid 
and results from a direct interaction of the hor- 
mone with thyrocytes. The observation that for- 
skolin is able to mimic the TSH effect strongly sug- 
gests that CAMP is the physiological mediator of 
the transcriptional action of the hormone. It clear- 
ly demonstrates that the Tg gene belongs to the 
family of transcription units subjected to regula- 
tion by cyclic nucleotides [3-81. Confirmation of 
this conclusion has recently been obtained in 
cultured dog thyroid cells by measurement 
of steady state levels of Tg mRNA (Van Heuvers- 
wyn, B., in preparation). The availability of clones 
DNA segments containing the Tg promoter [25] 
makes the thyroid system an attractive model to in- 
vestigate the molecular mechanisms involved in 
gene control by CAMP. 
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